Skip to content

Study to establish effective measures for COVID-19 in psychiatric medical institutes

Study to establish effective measures for COVID-19 in psychiatric medical institutes - Measures for COVID-19 in psychiatry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041557
Enrollment
150
Registered
2020-09-01
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Representatives of certified psychiatrist-training core facilities registered on the Japanese Society of Psychiatry and Neurology (2) Representatives of the Japanese Society of Psychiatry and Neurology

Exclusion criteria

Exclusion criteria: Not particular

Design outcomes

Primary

MeasureTime frame
Narrative descriptions regarding good practices against COVID-19 reported from psychiatric medical institutes

Countries

Japan

Contacts

Public ContactHiroaki Tomita

Tohoku University Graduate School of Medicine Department of Psychiatry

htomita@med.tohoku.ac.jp0227177262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026